Balanced news tone
News Sentiment
ACL sentiment intelligence
Australian Clinical Labs Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
15 relevant articles
News tone and price action are not far from neutral.
88/100 classification confidence.
directly relevant articles
high-authority source matches
+1.4% over one week, +11.2% over four weeks, trend inactive, and near fair-value range.
Why Australian Clinical Labs Is Back on the Small-Cap Radar
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
88/100 classification
One-week reaction
1.4%
Price digesting
Trend fit
Trend inactive
11.2% over four weeks
Fair value
-16.9%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
12
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Kalkine Media
Direct company coverage
Why Australian Clinical Labs Is Back on the Small-Cap Radar
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 01:54
- Source
- Kalkine Media
simplywall.st
Direct company coverage
ASX Penny Stock Highlights: Australian Clinical Labs Among 3 Noteworthy Picks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 02:57
- Source
- simplywall.st
Kalkine
Direct company coverage
Australian Clinical Labs Slips After Appointing Former Healthscope Boss as CEO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Kalkine
grafa.com
Direct company coverage
Greg Horan appointed CEO of Australian Clinical Labs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- grafa.com
Kalkine
Direct company coverage
Australian Clinical Labs (ASX:ACL) Shares Draw Attention After Latest Appendix 3C Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Kalkine
simplywall.st
Direct company coverage
A Look At Australian Clinical Labs (ASX:ACL) Valuation After Softer Half Year Earnings And Interim Dividend
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Is Australian Clinical Labs (ASX:ACL) Balancing Dividends And Leadership Change Or Stretching Its Strategy?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Feb 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Australian Clinical Labs H1 2026 Margin Compression Challenges Bullish Efficiency Narratives
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 17 Feb 2026 08:00
- Source
- simplywall.st
The Motley Fool Australia
Direct company coverage
Australian Clinical Labs shares hit record low as CEO to exit
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
Why Audinate, Australian Clinical Labs, Coronado, and Treasury Wine shares are sinking today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- The Motley Fool Australia
Stocks Down Under
Direct company coverage
Australian Clinical Labs (ASX:ACL) The Statutory Hit Spooked Investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- Stocks Down Under
The Motley Fool Australia
Direct company coverage
Why Australian Clinical Labs, Karoon Energy, MA Financial, and Silex shares are roaring higher today
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Oct 2025 07:00
- Source
- The Motley Fool Australia
Market source
Direct company coverage
Analyst Estimates: Here's What Brokers Think Of Australian Clinical Labs Limited (ASX:ACL) After Its Full-Year Report
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 28 Aug 2025 07:00
- Source
- Market source
Market source
Direct company coverage
Is Australian Clinical Labs Limited (ASX:ACL) Potentially Undervalued?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Aug 2025 07:00
- Source
- Market source
Market source
Direct company coverage
With 53% ownership of the shares, Australian Clinical Labs Limited (ASX:ACL) is heavily dominated by institutional owners
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Sep 2022 07:00
- Source
- Market source